| Literature DB >> 27658984 |
Anand M Prasad1, Pimonrat Ketsawatsomkron2, Daniel W Nuno3, Olha M Koval1, Megan E Dibbern1, Ashlee N Venema1, Curt D Sigmund4, Kathryn G Lamping5, Isabella M Grumbach6.
Abstract
Angiotensin-II (Ang-II) is a well-established mediator of vascular remodeling. The multifunctional calcium-calmodulin-dependent kinase II (CaMKII) is activated by Ang-II and regulates Erk1/2 and Akt-dependent signaling in cultured smooth muscle cells in vitro. Its role in Ang-II-dependent vascular remodeling in vivo is far less defined. Using a model of transgenic CaMKII inhibition selectively in smooth muscle cells, we found that CaMKII inhibition exaggerated remodeling after chronic Ang-II treatment and agonist-dependent vasoconstriction in second-order mesenteric arteries. These findings were associated with increased mRNA and protein expression of smooth muscle structural proteins. As a potential mechanism, CaMKII reduced serum response factor-dependent transcriptional activity. In summary, our findings identify CaMKII as an important regulator of smooth muscle function in Ang-II hypertension in vivo. Published by Elsevier Inc.Entities:
Keywords: Ang-II; CaMKII; Remodeling; Smooth muscle
Mesh:
Substances:
Year: 2016 PMID: 27658984 PMCID: PMC5164857 DOI: 10.1016/j.vph.2016.09.007
Source DB: PubMed Journal: Vascul Pharmacol ISSN: 1537-1891 Impact factor: 5.773